BioBAT Brings Bioscience Research To Brooklyn, New York
05/24/2010
"With the development of BioBAT, together with the East River Science Park set to open this fall, we are building 10 times the amount of commercial lab space that's currently available," said New York City Mayor Michael R. Bloomberg.
The City invested $12 million in the project, and the state offered $48 million of funding. Some organizations, such as the International AIDS Vaccine Initiative, are already located there, and will be joined by several others.
"BioBAT's laboratory, office, and manufacturing space on the Brooklyn waterfront is designed for larger companies and offers affordable rents, convenient transportation, and access to all the leading academic research centers in the city," said SUNY Downstate President John C. LaRosa.
The Brooklyn Army Terminal is a 97-acre facility owned by the city and managed by the New York City Economic Development Corporation. BioBAT is a nonprofit corporation that was created to encourage the development of commercial bioscience research, development, and manufacturing in Brooklyn. The architecture firm HOK will design the facility.
Project Announcements
France-Based Sartorius Stedim Plans Marlborough, Massachusetts, Bioprocess Operations
12/10/2024
357 Brewers Expands Myrtle Beach, South Carolina, Operations
12/05/2024
Koch Foods Expands Morton, Mississippi, Operations
12/04/2024
Irving Tissue Expands Macon, Georgia, Production Operations
12/03/2024
General Mills Expands Hannibal, Missouri, Production Operations
12/03/2024
US Foods Expands Buda, Texas, Distribution Operations
12/03/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024